The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

January 13, 2021 Auto Bot Casirivimab, Imdevimab, Regeneron 0

Shots:

  • Roche confirms that the US govt. will purchase additional supply of Regeneron’s Ab cocktail for use in non-hospitalized COVID-19 patients as part of Operation Warp Speed
  • The agreement additional supply of Regeneron’s Ab cocktail for use in non-hospitalized COVID-19 patients as part of Operation Warp Speed.
  • The cocktail has received the US FDA’s EUA for recently diagnosed, high-risk, mild to moderate COVID-19 patients. Roche & Regeneron collaborated to develop and manufacture casirivimab and imdevimab under which Regeneron is distributing it in the US while Roche will be responsible for distribution outside the US

Click here ­to­ read full press release/ article | Ref: Roche | Image: Bloomberg

The post The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19 first appeared on PharmaShots.